ETV6 is an inclusion eligibility criterion in 3 clinical trials for congenital mesoblastic nephroma, of which 3 are open and 0 are closed. Of the trials that contain ETV6 status and congenital mesoblastic nephroma as inclusion criteria, 2 are phase 1/phase 2 (2 open) and 1 is phase 2 (1 open) [3].

NTRK1 is an inclusion eligibility criterion in 3 clinical trials for congenital mesoblastic nephroma, of which 3 are open and 0 are closed. Of the trials that contain NTRK1 status and congenital mesoblastic nephroma as inclusion criteria, 2 are phase 1/phase 2 (2 open) and 1 is phase 2 (1 open) [3].

NTRK2 is an inclusion eligibility criterion in 3 clinical trials for congenital mesoblastic nephroma, of which 3 are open and 0 are closed. Of the trials that contain NTRK2 status and congenital mesoblastic nephroma as inclusion criteria, 2 are phase 1/phase 2 (2 open) and 1 is phase 2 (1 open) [3].

NTRK3 is an inclusion eligibility criterion in 3 clinical trials for congenital mesoblastic nephroma, of which 3 are open and 0 are closed. Of the trials that contain NTRK3 status and congenital mesoblastic nephroma as inclusion criteria, 2 are phase 1/phase 2 (2 open) and 1 is phase 2 (1 open) [3].